Bath & Body Works (NYSE:BBWI) Price Target Raised to $41.00

Bath & Body Works (NYSE:BBWI) had its target price increased by JPMorgan Chase & Co. from $39.00 to $41.00 in a report published on Friday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

BBWI has been the subject of a number of other reports. Argus reiterated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Barclays raised their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. Piper Sandler boosted their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Finally, TD Cowen lifted their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.19.

Bath & Body Works Stock Down 0.8 %

NYSE:BBWI opened at $36.98 on Friday. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm’s 50 day moving average is $36.86 and its two-hundred day moving average is $33.61. The company has a market cap of $8.01 billion, a P/E ratio of 9.02, a P/E/G ratio of 1.01 and a beta of 1.82.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.48 EPS. Research analysts forecast that Bath & Body Works will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.16%. Bath & Body Works’s payout ratio is 19.51%.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently modified their holdings of the business. Fifth Third Wealth Advisors LLC grew its stake in Bath & Body Works by 4.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after purchasing an additional 324 shares in the last quarter. TD Private Client Wealth LLC grew its stake in shares of Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares in the last quarter. UMB Bank n.a. increased its holdings in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after buying an additional 335 shares during the last quarter. Avior Wealth Management LLC increased its holdings in Bath & Body Works by 30.3% during the fourth quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock worth $76,000 after buying an additional 453 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in Bath & Body Works by 34.4% during the third quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock worth $79,000 after acquiring an additional 635 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.